Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
Developing broadly applicable neoantigen-directed adoptive cell therapies (ACTs) is challenging because each cancer patient has an unique neoantigen repertoire. Here, the authors present the crystal structures of tumor-specific T cell receptors (TCRs) that recognize a shared neoepitope arising from...
Guardado en:
Autores principales: | Daichao Wu, D. Travis Gallagher, Ragul Gowthaman, Brian G. Pierce, Roy A. Mariuzza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/539421cdbf2649ba84e049f00249ee1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
por: Rui Yin, et al.
Publicado: (2021) -
Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR
por: Yaxin Dai, et al.
Publicado: (2018) -
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
por: Satoshi Inoue, et al.
Publicado: (2019) -
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Michael S. Hwang, et al.
Publicado: (2021) -
Structural basis for the recognition of sulfur in phosphorothioated DNA
por: Guang Liu, et al.
Publicado: (2018)